| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/14/2014 | US8628752 Methods of identifying HSP90 inhibitors with less ocular toxicity |
| 01/14/2014 | US8628751 Pyrazine derivatives for optical imaging and therapy |
| 01/14/2014 | US8628749 Radioimmunoconjugates and uses thereof |
| 01/14/2014 | CA2601069C Contrast agents for magnetic resonance imaging |
| 01/14/2014 | CA2561073C Composition and method for cancer treatment |
| 01/14/2014 | CA2439925C Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 01/09/2014 | WO2014007821A1 Compositions and methods for detecting anastomosis leakage |
| 01/09/2014 | WO2014006254A1 Nanoparticles coated with gelatin |
| 01/09/2014 | WO2014005383A1 Invisible radiography material for early tumour diagnosis and preparation method thereof |
| 01/09/2014 | WO2013001309A3 Microbubble generation |
| 01/09/2014 | US20140010763 Activatable fluorogenic compounds and uses thereof as near infrared probes |
| 01/09/2014 | US20140010762 Imaging agents |
| 01/09/2014 | US20140010761 Form of hexyl-5-aminolevulinate hydrochloride and methods of using the same |
| 01/09/2014 | US20140010760 Hypoxia-Targeted Polymeric Micelles For Cancer Therapy And Imaging |
| 01/09/2014 | US20140010757 Imaging methods using engineered integrin binding peptides |
| 01/09/2014 | US20140010755 Multi-encapsulated formulations made with oxidized cellulose |
| 01/08/2014 | EP2682132A1 Composition and method for detection of demineralisation |
| 01/08/2014 | EP2682131A1 Switching-type fluorescent nanoparticle probe, and fluorescent molecular imaging method using same |
| 01/08/2014 | EP2680869A2 Homeopathic therapeutic method and compositions |
| 01/08/2014 | CN103502465A Method for detecting cancer cell using fluorescently labeled L-glucose derivative, and cancer cell-imaging agent comprising fluorescently labeled L-glucose derivative |
| 01/08/2014 | CN103501769A Star polymer nanoshells and methods of preparation thereof |
| 01/08/2014 | CN103497972A Japanese encephalitis virus (JEV) infectious clone with luciferase gene and building method and application thereof |
| 01/08/2014 | CN103497347A Preparation method of dual functional chitosan microspheres |
| 01/08/2014 | CN103497217A 2-aryl benzothiazole compound with high affinity with A(beta) plaque and preparation method and application thereof |
| 01/08/2014 | CN103497120A Process for synthesizing diatrizoic acid by using solid-phase load method |
| 01/08/2014 | CN103495187A Type-B ultrasonic traditional Chinese medicinal gastroenterography assistant and method for preparing same |
| 01/08/2014 | CN103495186A Manganese oxide nanoparticle contrast agent for specifically targeting brain glioma |
| 01/08/2014 | CN103495185A Preparation method of functionalized polyethyleneimine-modified multi-wall carbon nano-tube magnetic resonance imaging contrast agent |
| 01/08/2014 | CN103495184A Medical polystyrene barium-coating method |
| 01/08/2014 | CN103495183A Chemotactic factor CCL20 and applications of gene thereof |
| 01/08/2014 | CN103495179A Polymer albumin nanosphere as well as preparation method and applications of nanosphere |
| 01/08/2014 | CN103494765A Porous silicon drug-eluting particles |
| 01/08/2014 | CN102895679B Shell structure nano material and preparation method thereof |
| 01/08/2014 | CN102584869B 2-nuclear magnetic resonance imaging contrast agent taking 2, 3-biquinoxaline as connecting body and preparation method thereof |
| 01/08/2014 | CN102399199B Preparation method of magnetic resonance imaging contrast agent |
| 01/07/2014 | US8626270 Cavity-filling biopsy site markers |
| 01/07/2014 | US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 01/07/2014 | US8623325 Azide modified charge sensitive channel proteins |
| 01/07/2014 | US8623323 Thickened beverages for dysphagia |
| 01/07/2014 | CA2616788C Oral preparation useful in measuring capacity to metabolize pyridine |
| 01/07/2014 | CA2587248C Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 01/07/2014 | CA2563694C Surface enhanced spectroscopy-active composite nanoparticles |
| 01/07/2014 | CA2464472C Antibody targeting compounds |
| 01/03/2014 | WO2014004912A1 Methods and devices for ultrasound contrast-assisted therapy |
| 01/03/2014 | WO2014004889A2 Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm |
| 01/03/2014 | WO2014003874A1 Method to enhance swallowing safety and appeal of beverages for treating dysphagia based on rheological and sensory parameters |
| 01/03/2014 | WO2014002100A1 Compositions comprising near-infrared fluorescent particles and uses thereof for imaging activated immune cells in the cns |
| 01/03/2014 | WO2014001424A1 Heat stable nanoparticle preparations and associated methods thereof |
| 01/03/2014 | WO2013169932A3 Methods to detect a fungal cell |
| 01/03/2014 | CA2876950A1 Preparation of composition comprising gas microbubbles |
| 01/02/2014 | US20140005074 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 01/02/2014 | US20140004051 Co-crystals and salts of contrast agents and imaging |
| 01/02/2014 | US20140004050 Self-quenching activatable cox-2-specific multi-modal molecular probes for diagnosis of cancers, inflammation, and immune system disorders |
| 01/02/2014 | US20140004049 Nanoprobes for sensing of reactive oxygen and reactive nitrogen species |
| 01/02/2014 | US20140004048 Water-soluble nanoparticles |
| 01/01/2014 | EP2679247A1 Carboxylic mannan-coated contrast agent for magnetic resonance imaging |
| 01/01/2014 | CN103492575A Nav1.7 knockout mice and uses thereof |
| 01/01/2014 | CN103492418A Antibodies against kidney associated antigen 1 and antigen binding fragments thereof |
| 01/01/2014 | CN103492417A Tumor specific antibodies and uses therefor |
| 01/01/2014 | CN103491983A Materials and methods relating to cardiovascular imaging |
| 01/01/2014 | CN103491980A Photodynamic therapy or diagnostic agent, using infrared-spectrum light |
| 01/01/2014 | CN103484524A Pharmacodynamic and toxicologic test methods for honeysuckle and aster immunoenhancer |
| 01/01/2014 | CN103483591A Amphipathic comb type polymer with antibody TRC105 and developing agent and preparation method |
| 01/01/2014 | CN103483487A Novel structure product, preparation method and use of styrenic resin |
| 01/01/2014 | CN103483243A Sulphonate pyridinium biology development material and preparing method thereof |
| 01/01/2014 | CN103482605A Method for preparing large number of carbon quantum dot biology imaging agents |
| 01/01/2014 | CN103480009A Bi-modal tumor targeted nano particle photographic developer and method for preparing same |
| 01/01/2014 | CN103480008A Thermal enhancement type organic-inorganic compound lipid nanometer liquid state fluorocarbon ultrasonic contrast agent and preparation method thereof |
| 01/01/2014 | CN103480007A Ultrasound contrast agents for molecular imaging |
| 01/01/2014 | CN103480006A Preparation method and application for multifunctional nanometer diagnosis and treatment agent integrating light emitting/CT/MR multi-mode imaging and tumor hyperthermia |
| 01/01/2014 | CN103480005A Dermatitis diagnostic patch and preparation method thereof |
| 01/01/2014 | CN102627615B Novel compound L-4-terazine-phenylalanine, preparation method and application thereof |
| 12/31/2013 | US8617809 Neoplasia screening compositions and methods of use |
| 12/31/2013 | US8617808 Cultispot assay |
| 12/31/2013 | US8617522 Multimodal nanoparticles for non-invasive bio-imaging |
| 12/31/2013 | US8617520 Cancer therapy |
| 12/31/2013 | US8617519 Injectable cross-linked hydrogels for biomaterial applications |
| 12/31/2013 | US8617515 Imaging of myelin basic protein |
| 12/31/2013 | US8617514 Tumor-targeted nanodelivery systems to improve early MRI detection of cancer |
| 12/27/2013 | WO2013191274A1 Method for rendering biological material transparent and processing kit for rendering biological material transparent |
| 12/27/2013 | WO2013190165A1 Compounds having magnetic functionality, implants or gels derived from same, and use of both in order to determine the enzyme activity of an enzyme |
| 12/27/2013 | WO2013189113A1 Targeted molecular imaging probe and method for in vivo molecular imaging |
| 12/27/2013 | CA2877058A1 Compounds with magnetic functionality, implants or gels derived thereof, and the use of both to measure the enzyme activity of an enzyme |
| 12/27/2013 | CA2876904A1 Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof |
| 12/26/2013 | US20130347134 Transgenic von willebrand factor animals and uses thereof |
| 12/26/2013 | US20130344004 Matrix metalloprotease targeting nucleic acids |
| 12/26/2013 | US20130344003 Immuno-therapy for cancer treatment using iron oxide nanoparticles |
| 12/26/2013 | US20130344002 Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
| 12/26/2013 | US20130344001 Indocyanine green-containing particles, photoacoustic-imaging contrast agent including the same, and method for producing the indocyanine green-containing particles |
| 12/26/2013 | US20130344000 Treatment of cognitive impairment in a subject with a neurological autoimmune disease |
| 12/26/2013 | US20130343999 Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications |
| 12/26/2013 | US20130343997 Metal Coating of Rare Earth Nano-Phosphors and Uses Thereof |
| 12/26/2013 | US20130343996 Graphite-coated magnetic nanoparticles |
| 12/26/2013 | US20130343995 Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy |
| 12/26/2013 | US20130343987 Myocardial perfusion imaging methods and compositions |
| 12/25/2013 | EP2675486A2 Prussian blue based nanoparticle as multimodal imaging contrast material |
| 12/25/2013 | EP2675485A2 Anti-mucin antibodies for early detection and treatment of pancreatic cancer |
| 12/25/2013 | EP2178817B1 A microsphere comprising an organic lanthanide metal complex |
| 12/25/2013 | EP2094310B1 Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production |
| 12/25/2013 | CN103467729A Polyethylene glycol-poly amino acid-polyester triblock polymer, preparation method and use thereof |